ORIGINAL FILING ON SCHEDULE 13G

Company

NEKTAR THERAPEUTICS

Filed

February 3, 2004

Accession Number

0000950123-04-001170

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →